Researchers have harnessed artificial intelligence to design complete functional bacteriophage genomes and to assist CRISPR gene-editing experiments. AI models trained on millions of viral genomes generated novel phage variants capable of killing bacteria, opening new avenues against antibiotic resistance. Separately, Stanford Medicine introduced CRISPR-GPT, an AI tool that guides researchers in designing gene-editing studies, streamlining development workflows and lowering barriers to genomic therapies. These advances represent significant strides in synthetic biology and genetic medicine, enhancing precision, speed, and innovation.